latest Market News

SMT (Sahajanand Medical Technologies), India’s number 2 manufacturer of medical stents are hoping to capture the number 1 spot in the market soon, surpassing the market’s top player Abbott Healthcare. They aim to do so in the next two to three years. SMT has already grabbed a stronger hold onto the stent market in India from 11 percent, recorded last year to 18 percent according to the latest statistics. SMT intends to take full...

  • Posted on : Saturday , 17th February 2018
  • ReadMore

NEW DELHI:  Indian companies are being called to invest in African power, infrastructure and farming sectors as a strong engagement with the country in terms of doing business in Africa is being promoted by the AfDB. African Development Bank (AfDB) wants to accelerate engagement with the Indian government in terms of expanding business prospects in Africa, AfDB President Akinwumi Adesina said during his first official visit to...

  • Posted on : Saturday , 17th February 2018
  • ReadMore

The National Health Protection Scheme (NHPS), also known as “Modicare”, India ambitious new healthcare plan will soon be a part of the pharmaceutical policy that is soon to be announced. “Modicare” has been hailed to be the largest healthcare scheme in the world. The scheme will see cover of up to Rs. 5 lakh provided to poor and vulnerable families for the treatment of serious medical conditions. The Union Budget has put...

  • Posted on : Saturday , 17th February 2018
  • ReadMore

 State-owned NLC India plans to aggressively bid for Indian railways' solar projects said Union minister Piyush Goyal.   The Railways Minister said, "Indian Railways plans to have a bidding process to soon come out for expanding the solar footprint of railways where NLC India Ltd is also having very aggressive plans and will be bidding very aggressively to try and get those contracts through the bidding...

  • Posted on : Friday , 16th February 2018
  • ReadMore

Dr Reddy’s Laborites (DRL) is working to increase its reach in the world’s second largest pharmaceutical market, China. Other major drug manufacturers like Cipla and Lupin are also exploring possible avenues in China.  The Chinese market is worth an astonishing $100-billion today, with local drug manufacturers and a number of multinationals, enjoying complete control over the market. India’s pharmaceutical exports of...

  • Posted on : Wednesday , 14th February 2018
  • ReadMore

  • Indiaexportnews.com: We deliver breaking news from across India and the globe and information on the latest top stories, business, Trade and export headlines.

    Important Links